Clinical trial

The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients

NCT05925647

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-08-01Date precision: day

Registry last updated2023-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Messenchymal stem cell secretomeDRUG

PlaceboDRUG

Sponsors & collaborators

Universitas Sebelas Maretlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05925647 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.